Capítulo 1. 4. Valoración pronóstica después del infarto agudo de miocardio. Viabilidad miocárdica

Bibliografía
 

1. De Busk R. Specialized testing after recent acute myocardial infarction. Ann Intern Med 1989; 110: 470-481
2. Epstein S, Palmeri S, Patterson R. Evaluation of patients after acute myocardial infarction. Indications for cardiac catheterization and surgical intervention. N Engl J Med 1982; 307: 1487-1492
3. Mark D. An overview of risk assessment in coronary artery disease.
Am J Cardiol 1994; 73:19B-25B
4. Kulick D, Rahimtoola S. Risk stratification in survivors of acute myocardial infarction: routine cardiaac catheterization and angiography is a reasonable approach in most patients. Am Heart J 1991; 121: 641-656
5. Nicod P, Gilpin E, Dittrich H, et al. Trends in use of coronary angiography in subacute phase of myocardial infarction. Circulation 1991; 84: 1004-1015 
6. Moss A, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990; 322: 743-753
7. Kaul S. Technical, economic,interpretative, and outcomes issues regarding utilization of cardiac imaging techniques in patients with known or suspected coronary artery disease. Am J Cardiol 1995; 75:18D-24D
8. The multicenter postinfarction research group: Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336
9. Stevenson R, Wilkinson P, Marchant B, et al. Relative value of clinical variables, treadmill stress testing and Holter ST monitoring for postinfarction risk stratification. Am J Cardiol 1994; 74: 221-225
10  O’Rourke R. Risk stratification after myocardial infarction. Clinical overview. Circulation 1991; 84(Suppl I): I177-I181
11. Emanuelsson H, Karlson B, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 1994; 15: 761-768
12. Mauri F, Maggioni A, Franzosi M, et al. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with thrombolytic agent.
J Am Coll Cardiol 1994; 24: 600-607
13. Kudenchuk P, Maynard C, Martin J, Wirkus M, Weaver W. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (MITI registry). Am J Cardiol 1996; 78:9-14.
14. Kober L, Torp C, Ottesen M, Rasmussen S, Lessing M, Skagen K. (TRACE group). Influence of gender in short-and-long-term mortality after acute myocardial infarction. Am J Cardiol 1996; 77: 1052-1056.
15. Becker R, Cannon C, Bovill E, Tracy R, et al. TIMI-III investigators. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 1996; 78:142-147
16. Mkparu F. QT dispersion: proposed technique for optimal risk stratification. Am J Med 1996; 72:1323
17. Meyers D. Relative survival benefits of risk factor modifications.
Am J Cardiol 1996; 77: 298-299
18. Kornowski R, Goldbourt U, Boyko V, et al. Clinical predictors of reinfarction among men and women after a first myocardial infarction.
Cardiology 1995; 86: 163-168
19. Lee K, Woodlief L, Topol E, Weaver D, Betriu A, et al. (GUSTO-I investigators). Predictors of 30-day mortality in the era of reperfusion for acute myocardil infarction. Results from an international trial of 41021 patients. Circulation 1995; 91: 1659-1668
20. Ohman E, Armstrong P, Christenson R, Granger C, et al. Cardiac Troponin T levels for risk stratification in acute myocardial ischemia.
N Engl J Med 1996; 335: 1333-1341
21. Leppo J, O’Brien J, Rothendler J et al. Dipyridamole-Thallium-201 scintigraphy in the prediction of future cardiac event after acute myocardial infarction. N Engl J Med 1984; 310: 1014-1018
22. Bosch X, Theroux P, Waters D, et al. Early postinfarction ischemic. Clinical, angiographic and prognostic significance.
Circulation 1987; 75: 988-995
23. The GISSI-3 APPI Study Group. Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction (the GISSI-3 APPI [ angina precoce post-infarto) study). Am J Cardiol 1996; 78: 1191-1197
24. Volpi A, de Vita C, Franzosi M, et al. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis.
J Am Coll Cardiol 1994; 24: 608-615
25. Mickley H. Transient myocardial ischemia after myocardial infarction.
Cardiology 1995; 86: 8-14
26. Stevenson R, Umachandran V, Rantadayalan K, et al. Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated by thrombolysis. Br Heart J 1993; 70: 415-420
27. Currie P, Ashby D, Saltissi S. Prognostic value of ambulatory ST segment monitoring compared with exercise testing at 1-3 months after acute myocardial infarction. Eur Heart J 1994; 15: 54-60
28. Gill J, Cairns J, Roberts R, Constantini L, el al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med 1996; 334: 65-70
29. Quintana M, Lindvall K, Ryden L, Brolund F. Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. Am J Cardiol 1995; 76: 1115-1121
30. Petretta M, Bianchi V, Pulcino A, et al. Continous electrocardiographic monitoring for more than one hour does not improve the prognostic value myocardial infarction. Am J Cardiol 1994; 73: 139-142
31. Bardsley W, Mankin H. Prueba de ejercicio. En Brandenburg R, Fuster V, Giuliani E, McGoon D ed: Cardiología. Fundamnetos y práctica.pg 491-512. Ed CEA S.A. Madrid 1989
32. Gianrosi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A Meta-analysis. Circulation 1989; 80: 87-98
33. Bolognese L, Sarasso G, Bongo A, et al. Stress testing in the period after infarction. Circulation 1991; 83(suppl III): III32-III37
34. Machecourt J, Longere P, Fagret D, et al. Prognostic value of Thallium-201-photon emission  computed tomographic myocardial perfusion imaging according to extent of myocardial defect: study in 1926 patients with follow-up at 33 months. mJ Am Coll Cardiol 1994; 23: 1096-1106
35. Bodenheimer M. Risk stratification in coronary disease: a contrary viewpoint. Ann Int Med 1992; 116: 927-936
36. Froelicher V, Perdue S, Pewen W, Risch M. Application of meta-analysis using and electronic spread sheet to exercise testing in patients after myocardial infarction. Am J Med 1987; 83: 1045-1053
37. Corbett J, Dehmer G, Lewis S, et al. The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction. Circulation 1981; 64: 535-544
38. Lee K, Pryor D, Peiper K, et al. Prognostic value of radionuclide angiography in medically treated patients wwith coronary artery disease:a comparison with clinical and catheterization variables. Circulation 1990; 82: 1705-1717
39. Port S. The role of radionuclide ventricuography in the assessment of prognosis in patients with CAD. J Nucl Med 1994; 35: 721-725
40. McGhie D, Willerson T, Corbett J. Radionuclide  assessment of ventricular function ans risk stratification after myocardial infarction.
Circulation 1991; 84(suppl I): I167-I176
41. Van Royen N, Jaffe C, Krumholz H, Johnson K, Lynch P, Natale A, Wackers F. Comparison and reproducibility of visual echocardiographic and cuantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996; 77: 843-850
42. Mahmarian J, Verani M. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease. Am J Cardiol 1991; 67: 2D-11D
43. Kotler T, Diamond G. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 1990; 113: 684-702
44. Beller G. Myocardial perfusion imaging with Thallium-201. J Nucl Med 1994; 35: 674-680
45. Gibson R, Watson D, Craddock G, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise Thallium-201 scintigraphy and coronary angiography.
Circulation 1983; 68: 321-336
46. Brown K. Prognostic value of Thallium-201 myocardial perfussion imaging: a diagnostic tool comes of age.
    Circulation 1991; 83: 363-381
47. Marie P, Danchin N, Durand T, Feldmann L, et al. Long Term trediction of major ischemic events by exercise Thallium 201 single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 879-886
48. Iskandrian A. Myocardial ischemia during pharmacological stress test.
Circulation 1993; 87: 1415-1417
49. Beller G. Pharmacologic stress imaging. JAMA 1991; 265: 633-638
50. Beer S, Heo J, Iskandrian A. Dipyridamole Thallium imaging. Am J Cardiol 1991; 67: 18D-26D
51.  Coletta C, Galati A, Greco G, Burattini M,et al. Prognostic value of high dose dipyridamole echocardiography patients in patients with chronic coronary artery disease and preserved left ventricular function. J Am Coll Cardiol 1995; 26: 887-894
52. Joye J, Schulman D, Lasorda D, et al. Intracoronary doppler guide wire versus stress single-photon emission computed tomegraphic Thallium-201 imaging in assessment of intermediate coronary stenoses.
J Am Coll Cardiol 1994; 24: 940-947
53. Miyagawa M, Kumano S, Sekiya M, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosfate in diagnosis of coronary artery disease.
J Am Coll Cardiol 1995; 26: 1196-1201
54. Mahmarian J, Pratt C, Nishimura S, et al. Quantitative adenosine Tl single-photon emission computed tomography for the early assessment of computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993; 87: 1197-1210
55. Berman  D, Kiat H, Van Train K, et  al. Myocardial perfussion imaging with technetium-99m-Sestamibi. Comparative analysis of available imaging protocols.  J Nucl Med 1994; 35:681-688 
56. McClellan J, Travin M, Herman S, Barsn J, et al. Prognostic importance of scintigraphic left  ventricular cavity dilation during intravenous dipyridamole technetium-99m Sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997; 79: 600-605 
57. Travin M, Dessouki A, Cameron T, Heller G. Use of exercise technetium-99m Sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75: 665-669
58. O’Keefe J, Barnhart C, Bateman T. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75: 25D-34D
59. Beleslin B, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia. Head to head comparison of exercise, dobutamine and dipyridamole tests. Circulation 1994; 90: 1168-1176
60. Mairesse G, Marwick T, Vanoverschelde J, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease?. Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (MIBI) perfusion scintigraphy. J Am Coll Cardiol 1994; 24: 920-927
61. Marangelli V, Iliceto S, Piccinni G, et al. Detection of coronary artery disease by digital stress echocardiography: comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography. J Am Coll Cardiol 1994; 24: 117-124
62. Poldermans D, Fioretti P, Boersma E, et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.
Am J Cardiol 1994; 73: 456-459
63. Ostojic M, Picano E, Beleslin B, et al. Dipyridamole-dobutamine echocardiography: a novel test for detection of milder forms of coronary artery disease. J Am Coll Cardiol 1994; 23: 1115-1122
64. Bolognese L, Rossi L, Sarasso G, et al. Silent versus symptomatic dipyridamole-induced ischemic after myocardial infarction: clinical and prognosis significance. J Am Coll Cardiol 1992; 19: 953-959
65. Chiarella F, Domenicucci S, Bellotti P, et al. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. Eur Heart J 1994; 15: 842-850
66. Picano E, Pingitore A, Sicari R, Minardi G, et al.(EPIC study). Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: a large-scale multicenter trial. J Am Coll Cardiol 1995; 26: 908-913
67. Mertes H, Sawada S, Ryan T, Segar D, et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography.
Circulation 1993; 88: 15-19
68. Schroder K, Voller H, Dingerkus H, Munzberg H, et al. Comparison of the diagnostic potential of four echocardiographic stress test shortly after acutre myocardial infarction: submaximal exercise, transesphageal atrial pacing, dipyridamole and dobutamine-atropine. Am J Cardiol 1996; 77: 909-914
69. Dennis C, Pool P, Perrins E, Mohiuddin S, et al. Stress testing with closed-loop arbutamine as an alternative to exercise. J Am Coll Cardiol 1995; 26:1151-1158 
70. Cohen A, Weber H, Chauvel C, Monin J, et al. Comparison of Arbutamine and exercise echocardiography in diagnosis myocardical ischemia. Am J Cardiol 1997; 79: 713-716
71. Reeder G, Smith H, Frye R. Cateterización y angiografía cardiaca. En Brandenburg R, Fuster V, Giuliani E, McGoon D Ed: Cardiología. Fundamentos y práctica. pag 491-512. Ediciones CEA SA. Madrid 1989.
72. Kulick D, Rahimtoola S. Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients. Am Heart J 1991; 121: 641-656
73. Moss A, Goldstein R, Hall J, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA 1993; 269: 2379-2385
74. Pitt B. Evaluation of the postinfarct patient. Circulation 1995, 91: 855-1860
75. Nicod P, Gilpin E, Dittrich H, et al. Trends in use of coronary angiography in subacute phase of myocardial infarction. Circulation 1991; 84: 1004-1015
76. Berman S, Kiat H, Friedman J, Diamond G. Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform. Am J Cardiol 1995; 75: 3D-13D
77. Sanz G, Castañer A, Betriu M, et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study.
N Engl J Med 1982; 306: 1065-1670
78. Caracciolo E, Davis K, Sopko G, Kaiser G, Corley S, Schaff H, TAylor H, Chaitman B. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation 1995; 91:2325-2334
79. Little W, Constantinescu M, Applegate R, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 1988; 78: 1157-1166
80. Knatterud G, Bourassa M, Pepine C, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12 week results of the asymptomatic cardiac ischemic pilot (ACIP) study. J Am Coll Cardiol 1994; 24: 11-20
81. CASS principal investigators. coronary artery surgery study (CASS): a randomized trial of coronary artery bypass: survival data. Circulation 1983; 68:939-950
82. The veterans administration coronary artery bypass surgery cooperative study group. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311:1333-1339
83. European coronary surgery study group. Long-term results of a prostective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2:1173-1180
84. Rahimtoola S. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina.
Circulation 1985; 72(suppl V): V123-V135
85. Bonow R. Radionuclide angiography for risk stratification of patients with coronary artery disease. Am J Cardiol 1993; 72: 735-739
86. Bittl J. Advances in coronary angioplasty. N Engl J Med 1996; 335: 1290-1302
87. The bypass angioplasty revascularization investigation (BARI) investigators. comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335:217-225
88. Roubin G, Harris P, Bernstein L, Kelly D. Coronary anatomy and prognosis after myocardial infarction in patients 60 years of age and younger. Circulation 1983; 67: 743-749
89. TIMI study group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. results of the TIMI phase II trial. N Engl J Med 1989; 320: 618-627
90. Spertus J, Weiss N, Every N, Weaver W. The influence of clinical risk factors on the use of angiography and revascularization after acute myocardial infarction. Arch Intern Med 1995; 155:2309-2316
91. Pilote L, Miller D, Califf R, Rao J, Weaver W, Topol E. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996; 335:1198-1205
92. Iskandrian A, Heo J. Optimizing patients selection for coronary angiography. Am J Cardiol 1995; 75: 14D-17D
93. Dilsizian V, Perrone-Filardi P, Arrighi J, et al. Concordance and discordance between stress-resdistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by PET. Circulation 1993; 88: 941-952
94. Braunwald E, Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction.Circulation 1982: 66:1146
95. Maddahi J, Schelbert H, Brunken R, DiCarli M. Role of Thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994; 35:707-715
96. Bonow R. Identification of viable myocardium. Circulation 1996; 94: 2674-2680
97. Gioia G, Powers J, Heo J, et al. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy.
Am J Cardiol 1995; 75: 759-762
98. Zimmermann R, Mall G, Rauch B, Zimmer G, et al. Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Circulation 1995; 91:1016-1021
99. Kaul S. Myocardial contrast echocardiography in coronary artery dosease:Potential applications using venous injections of contrast.
Am J Cardiol 1995; 75:61D-68D
100. Grayburn P, Erickson J, Escobar J, Womack L, Velasco C. Peripheral intravenous myocardial contrast echocardiography using 2% Dodecafluoropentano emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995; 26: 1340-1347
101. DeFilippi C, Willet D, Iran W, Eichhorn E, Velasco C, Grayburn P. Comparison of myocardial contrast echocardiography an low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemia heart disease. Circulation 1995; 92:2863-2868
102. Smart S. The clinical utility of echocardiography in the assessment of myocardial viability. J Nucl Med 1994; 35:49S-58S
103. Cigarroa C, de Felippi C, Brickner E, Alvarez L, Wait M, Grayburn P. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.
Circulation 1993; 88: 430-436
104. Duchak J, Smart S, Wynsen J, et al. Low dose dobutamine induced infarction zone wall thickening correlates with thallium by delayed SPECT imaging. Circulation 1992; 86: 1384
105. Salustri A, Elhendy A, Garyfallydis P, et al. Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994; 74: 853-856
106. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994; 24: 624-630
107. Arnese M, Cornel J, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. Circulation  1995; 91: 2748-2752
108. Panza J, Dilsizian V, Laurienzo J, Curier R, Katsiyiannis P. Relation between thallium uptake and contractile response to dobutamine. Circulation 1995; 91:990-998 
109. Perrone-Filardi P, Pace L, Pastaro M, Squame F, et al. Asessment of myocardial viability  in patients with chronic coronary artery disease: rest-4 hour-24 hour thallium tomography versus dobutamine echocardiography.      Circulation 1996; 94: 2712-2719
110. Rahimtoola S. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996; 94: 3055-3061
111. Schelberth HR. Metabolic imaging to assess myocardial viability.
J Nucl Med 1994; 35:8S-14S
112. Bergmann S. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viavle myocardium. J Nucl Med 1994; 35:15S-22S
113. Clarke K, Veech R. Metabolic complexities in cardiac imaging. Circulation 1995; 91:2299-2301
114. Van der Wall E, Vliegen H, Roos A, Bruschke A. Magnetic resinance imaging in coronary artery disease. Circulation 1995; 92:2723-2739
115. Blackwell G, Pohost G. The evolving role of MRI in the assessment of coronary artery disease. Am J Cardiol 1995; 75:74D-78D
116. Kajinami K, Seki H, Takekoshi N, Mabuchi H. Noninvasive prediction of coronary atherosclerosis by cuantification of coronary artery calcification using electron beam computed tomography. Comparison with ECG and Thallium exercise stress test results. J Am Coll Cardiol 1995; 26:1209-1221
117.  Achenbach S, Moshage W, Ropers D, Nossen J, Bachmann K. Noninvasive three-dimensional visualization of coronary artery bypass grafts by electron beam tomography. Am J Cardiol 1997; 79: 856-861
118.  Viskin S., Belhassen B. Should Electrophysiological Studies be performed in asymptomatic patients following myocardial infarction?.
Pace 1994; 17:1082-1089 
119.  Cain M, Anderson J, Arnsdort M, Mason J, Scheinman B, Waldo A. Signal Averaged Electrocardiography.
J Am Coll Cardiol 1996; 27:238-249
120.  Malik M (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology). Heart Rate Variability. Standars of measurement, physiological interpretation and clinical use. Circulation 1996; 93:1043-4065.